MiR-126-3p, peaking at day eight, was identified as a potential biomarker for coronary artery disease [55], while miR193a-5p with a peak at day 12 was shown to repress proliferation and migration of cardiac stem cells (CSCs) through the downregulation of c-kit [56]. This evidence concerns the gene KIT and coronary artery disorder.